Opendata, web and dolomites

DosiKit TERMINATED

DosiKit, a first portable field medical device for fast triage of people after external irradiation

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 DosiKit project word cloud

Explore the words cloud of the DosiKit project. It provides you a very rough idea of what is the project "DosiKit" about.

market    competencies    instrument    singapore    revenue    irradiation    accident    nuclear    radiation    israel    worldwide    pbi    prototype    bio    business    validation    international    validated    giving    seasoned    specialist    transportable    radiological    exposure    classify    actions    atomic    risk    requiring    nrbc    booster    triage    scientific    fulfil    final    oral    communications    emergency    partial    people    forecasted    2022    performed    commercial    biological    energy    founded    dosikit    acubens    hospitals    army    staff    published    fast    continued    initial    medical    starting    biodosimetry    undergoing    dosimetric    innovative    protected    individuals    fto    initiated    managers    care    schedule    survey    team    uniting    lack    french    exposed    tools    sales    technological    body    2014    cartography    15    irradiated    unmet    responders    crisis    experimented    2024    changer    patents    loi    sme    germany    minutes    reached    invented    critical    45    collaborations    2009    commercialize    expose    ip    game    potentially    device    young    doctors    usa    publications    armies    trl6    regulatory    exercise    contact    diagnostic   

Project "DosiKit" data sheet

The following table provides information about the project.

Coordinator
ACUBENS 

Organization address
address: 15 RUE PIERRE GILLES DE GENNES
city: NANTERRE
postcode: 92160
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2020-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ACUBENS FR (NANTERRE) coordinator 50˙000.00

Map

 Project objective

Acubens was founded in 2014, to develop and commercialize new game-changer medical diagnostic devices around NRBC emergency. Our team gathers young and experimented doctors, and seasoned business managers, uniting their competencies to develop nuclear/radiological/biological innovative transportable biodosimetry devices. Nuclear/radiological accident can expose individuals to radiation, with the need for fast triage of potentially exposed people requiring immediate medical care. There is today a lack of irradiation biodosimetry tools that can be used in the field, by non-specialist staff, giving immediate results and exposure cartography in case of Partial-Body irradiation (PBI). To fulfil this critical unmet need for better initial crisis management, we invented the DosiKit device and fast test (45 minutes) to identify and classify irradiated individuals, directly in the field. This development was initiated in 2009 by the French Atomic Energy Commission within the European Commission program, BOOSTER (‘BiO-dOSimetric Tools for triagE to Responders’), and then continued by Acubens. DosiKit technology is protected by 3 international patents and has reached TRL6 with a prototype validated in a large-scale exercise performed with the French army. Several collaborations are undergoing for biological validation with French research institute and hospitals. Scientific and technical development was published in 3 scientific publications and many international oral communications. A strong contact has established with French, Germany, Israel, US and Singapore armies (LoI). This DosiKit product will be on the market in 2022, starting in Europe and then extending worldwide. Forecasted sales revenue is 15 M€ in 2024. The objectives of this phase 1 SME-Instrument are: (1) the final Biological and Technological validation of the device, (2) IP, FTO, Regulatory and risk assessment studies and (3) a market survey in Europe and USA to schedule our commercial actions.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DOSIKIT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DOSIKIT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

In-Heal (2019)

Standardised administration device for raw medical herbs

Read More  

MCBD (2019)

MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE

Read More  

SmartDegrees (2020)

First anti-fraud plataform for the registration and certification of diplomas and academic certificates based in blockchain

Read More